As of 2026-06-13, the Fair Value of BiondVax Pharmaceuticals Ltd (BVXV) is -13.29 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.36 USD, the upside of BiondVax Pharmaceuticals Ltd is -1,077.32%.
With the market price of 1.36 USD and our fair value calculation, BiondVax Pharmaceuticals Ltd (BVXV) is not a good investment. Investing in BVXV stocks now will result in a potential loss of 1,077.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | - | - | 5Y Avg | |
| Net income | -22.92 | -28.53 | - | - | -25.72 | |
| YoY growth | -153.91% | -24.47% | - | - | -89.19% | |
| Market Cap (mil) | 4.94 |
| P/E | |
| Forward P/E |
| EPS | -7.85 |
| Avg earnings growth rate | -89.19% |
| TTM earnings | -28.53 |